Disbrow Joshua R.

Average Profitability
<0.0001%
Insider Buys Quantity
10
Insider Buys Sum
$1.29M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Disbrow Joshua R.

According to the SEC Form 4 filings, Disbrow Joshua R., being in a position of

  1. Chief Executive Officer at Aytu BioPharma, Inc.,
    оver the last 12 months, has bought 15000 shares for $19,500, and sold 0 shares,
    over all time since 2016-01-20, has bought 1785500 shares for $1.23M, and sold 0 shares.

The largest purchase of all time was on 2016-11-02 and amounted to 333332 shares of Aytu BioPharma, Inc. for $559,998.

Biography of Disbrow Joshua R.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Prismo
Buys
 $77,7332100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

Prismo
Prismo
2025-02-28PurchaseAytu BioPharma, Inc.
AYTU
Chief Executive Officer
15,000
0.245%
$1.30$19,500-2.71%
2024-07-29PurchaseZynex, Inc.
ZYXI
director
7,000
0.022%
$8.32$58,233-4.32%
2023-06-14PurchaseAytu BioPharma, Inc.
AYTU
Chief Executive Officer
14,000
0.3999%
$1.86$26,079+59.14%
2022-12-19PurchaseAytu BioPharma, Inc.
AYTU
Chief Executive Officer
112,371
0.1842%
$0.22$25,048-47.73%
2022-11-18PurchaseAytu BioPharma, Inc.
AYTU
Chief Executive Officer
222,000
0.3705%
$0.24$52,614-50%
2019-12-19PurchaseAytu BioPharma, Inc.
AYTU
55,000
0.3354%
$0.89$48,824+44.58%
2018-03-06PurchaseAytu BioPharma, Inc.
AYTU
Chief Executive Officer
226,105
2.044%
$0.45$101,747-49.76%
2016-11-02PurchaseAytu BioPharma, Inc.
AYTU
Chief Executive Officer
333,332
4.4318%
$1.68$559,998-70.09%
2016-05-06PurchaseAytu BioPharma, Inc.
AYTU
Chief Executive Officer
500,000
1.3724%
$0.40$200,000-75.51%
2016-01-20PurchaseAytu BioPharma, Inc.
AYTU
Chief Executive Officer
307,692
1.1046%
$0.65$200,000-87.14%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Sells over the last 12 months, USD